Neuren Pharmaceuticals (ASX:NEU) has announced it will develop its drug candidate NNZ-2591 to treat hypoxic-ischemic ...

The ASX 200 biotech stock notes that HIE is a devastating type of brain injury caused when a baby's brain does not receive ...

The Health Service Executive has said that work is continuing on a review of maternity services at Portiuncula University ...

Birth injuries can take an emotional toll on both the child and the parents. For the child, the consequences can include ...

Amid the downbeat narrative about US healthcare policy and cuts to funding agencies, a ‘Magnificent Seven’ of ASX drug ...

PARENTING charities have issued an urgent warning to parents over an “unsafe” breastfeeding technique, following the tragic ...

Through the millennia, humans have blithely ignored early warnings about the adverse health effects of everyday products and ...

Eight separate shortcomings were identified by a coroner over the death of Ida Lock - as he attacked the 'callous and ...

James 'Jimmy' Alderman was being breastfed by his mother, Ellie, inside a sling that she wore 'snugly', not tightly - she ...

Several ASX healthcare companies are leading the charge in finding new treatments for complex neurological disorders.

These shares are avoiding the market weakness on Thursday. But why? The post Why Core Lithium, Healius, Neuren, and Reject Shop shares are storming higher today appeared first on The Motley Fool ...

Photo / 123rf A mother who lost a child previously to unexplained circumstances said she panicked as her new 4-month-old baby ...